AJG:肝硬化门静脉血栓形成预测因素

2013-05-03 AJG dxy

    近日,日本学者Hitoshi Maruyama发表论文,旨在调查肝硬化患者新发性门静脉血栓形成(PVT)的预测因素和长期转归。研究指出,侧支血管的发展是病毒性肝硬化患者发生PVT的一个重要预测因素。自发性消退或外观不变是血栓形成的最常见转归,对预后影响不大。该文在线发表于《美国胃肠病学杂志》。  检测150例病毒性肝硬化的PVT(通过多普勒超声诊断)发病率和预

    近日,日本学者Hitoshi Maruyama发表论文,旨在调查肝硬化患者新发性门静脉血栓形成(PVT)的预测因素和长期转归。研究指出,侧支血管的发展是病毒性肝硬化患者发生PVT的一个重要预测因素。自发性消退或外观不变是血栓形成的最常见转归,对预后影响不大。该文在线发表于《美国胃肠病学杂志》。
  检测150例病毒性肝硬化的PVT(通过多普勒超声诊断)发病率和预测因素以及预后,无PVT患者为基线。
  28%的患者发展为PVT(42/150),1、5、8-10年的累积发生率分别为12.8%、20%和38.7%。基线最大侧支血管流量是血栓形成的一个独立危险因素(危险比:3.922;95%可信区间,3.697-4.415;P<0.0001)。最大侧支血管流速>10 cm/s的PVT患者1、5、10年累计发生率(19.1%,27%和78.4%)与最大侧支血管流速≤10 cm/s患者相比(8.6%,16.3%和24.7%)明显增高(P=0.0303);最大侧支血管流量>400 ml/min的PVT患者1、5、10年累计发生率(27.4%,36.5%和74.6%)与流量≤400 ml/min的患者相比(10.6%,16.2%和28.8%)明显增高(P=0.0075)。血栓形成的自然进程47.6%好转,45.2%没有改变,7.2%恶化。改进的患者与其他患者相比,血栓检测最大侧支血管的直径和流量明显减小。血栓形成组和非血栓形成组累积生存率相似。
肝硬化相关的拓展阅读:


De novo Portal Vein Thrombosis in Virus-Related Cirrhosis: Predictive Factors and Long-Term Outcomes.
OBJECTIVES
The objective of this study is to investigate predictive factors and long-term outcomes of de novo portal vein thrombosis (PVT) in cirrhosis.
METHODS
The incidence and factors predictive of PVT (diagnosed by Doppler ultrasound) and prognosis were examined in 150 patients with virus-related cirrhosis but without PVT at baseline.
RESULTS
PVT developed in 28% of patients (42/150), with cumulative incidence of 12.8%, 20%, and 38.7% at 1, 5, and 8-10 years, respectively. The baseline flow volume in the largest collateral vessel was an independent risk factor for thrombosis (hazard ratio, 3.922; 95% confidence intervals, 3.697-4.415; P<0.0001). The cumulative incidence of PVT at 1, 5, and 10 years was significantly higher in patients with the largest collateral vessel velocity >10 cm/s (19.1%, 27%, and 78.4%, respectively) compared with those with velocity ≤10 cm/s (8.6%, 16.3%, and 24.7%, respectively, P=0.0303), and higher in patients with volume >400 ml/min (27.4%, 36.5%, and 74.6%, respectively) compared with those with volume ≤400 ml/min (10.6%, 16.2%, and 28.8%, respectively, P=0.0075). The natural course of thrombosis was improvement in 47.6%, unchanged in 45.2%, and worsened in 7.2%. The diameter and flow volume in the largest collateral vessel at the time of thrombus detection were significantly smaller in the improved patients than the others. The cumulative survival rate was similar between the thrombosis group and non-thrombosis group.
CONCLUSIONS
Development of collateral vessels was a significant predictive factor for the occurrence of PVT in virus-induced cirrhosis. Spontaneous resolution or unchanged appearance was the most common outcome of thrombosis, which had little influence on prognosis.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1697158, encodeId=fc24169e158a6, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Jul 31 18:53:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950736, encodeId=94e41950e366e, content=<a href='/topic/show?id=93089e161db' target=_blank style='color:#2F92EE;'>#门静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97161, encryptionId=93089e161db, topicName=门静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2978132, createdName=minzju5052, createdTime=Thu Mar 06 14:53:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057215, encodeId=40b9205e215d8, content=<a href='/topic/show?id=18982222db' target=_blank style='color:#2F92EE;'>#AJG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2222, encryptionId=18982222db, topicName=AJG)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2978132, createdName=minzju5052, createdTime=Tue Jan 28 22:53:00 CST 2014, time=2014-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955175, encodeId=8dc919551e59e, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Fri Jun 07 23:53:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264183, encodeId=2d7112641832c, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435135, encodeId=307a1435135c7, content=<a href='/topic/show?id=6d779e14916' target=_blank style='color:#2F92EE;'>#门静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97149, encryptionId=6d779e14916, topicName=门静脉)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483231, encodeId=855f14832316d, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
    2013-07-31 fusion
  2. [GetPortalCommentsPageByObjectIdResponse(id=1697158, encodeId=fc24169e158a6, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Jul 31 18:53:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950736, encodeId=94e41950e366e, content=<a href='/topic/show?id=93089e161db' target=_blank style='color:#2F92EE;'>#门静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97161, encryptionId=93089e161db, topicName=门静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2978132, createdName=minzju5052, createdTime=Thu Mar 06 14:53:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057215, encodeId=40b9205e215d8, content=<a href='/topic/show?id=18982222db' target=_blank style='color:#2F92EE;'>#AJG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2222, encryptionId=18982222db, topicName=AJG)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2978132, createdName=minzju5052, createdTime=Tue Jan 28 22:53:00 CST 2014, time=2014-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955175, encodeId=8dc919551e59e, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Fri Jun 07 23:53:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264183, encodeId=2d7112641832c, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435135, encodeId=307a1435135c7, content=<a href='/topic/show?id=6d779e14916' target=_blank style='color:#2F92EE;'>#门静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97149, encryptionId=6d779e14916, topicName=门静脉)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483231, encodeId=855f14832316d, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1697158, encodeId=fc24169e158a6, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Jul 31 18:53:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950736, encodeId=94e41950e366e, content=<a href='/topic/show?id=93089e161db' target=_blank style='color:#2F92EE;'>#门静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97161, encryptionId=93089e161db, topicName=门静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2978132, createdName=minzju5052, createdTime=Thu Mar 06 14:53:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057215, encodeId=40b9205e215d8, content=<a href='/topic/show?id=18982222db' target=_blank style='color:#2F92EE;'>#AJG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2222, encryptionId=18982222db, topicName=AJG)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2978132, createdName=minzju5052, createdTime=Tue Jan 28 22:53:00 CST 2014, time=2014-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955175, encodeId=8dc919551e59e, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Fri Jun 07 23:53:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264183, encodeId=2d7112641832c, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435135, encodeId=307a1435135c7, content=<a href='/topic/show?id=6d779e14916' target=_blank style='color:#2F92EE;'>#门静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97149, encryptionId=6d779e14916, topicName=门静脉)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483231, encodeId=855f14832316d, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
    2014-01-28 minzju5052
  4. [GetPortalCommentsPageByObjectIdResponse(id=1697158, encodeId=fc24169e158a6, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Jul 31 18:53:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950736, encodeId=94e41950e366e, content=<a href='/topic/show?id=93089e161db' target=_blank style='color:#2F92EE;'>#门静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97161, encryptionId=93089e161db, topicName=门静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2978132, createdName=minzju5052, createdTime=Thu Mar 06 14:53:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057215, encodeId=40b9205e215d8, content=<a href='/topic/show?id=18982222db' target=_blank style='color:#2F92EE;'>#AJG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2222, encryptionId=18982222db, topicName=AJG)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2978132, createdName=minzju5052, createdTime=Tue Jan 28 22:53:00 CST 2014, time=2014-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955175, encodeId=8dc919551e59e, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Fri Jun 07 23:53:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264183, encodeId=2d7112641832c, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435135, encodeId=307a1435135c7, content=<a href='/topic/show?id=6d779e14916' target=_blank style='color:#2F92EE;'>#门静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97149, encryptionId=6d779e14916, topicName=门静脉)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483231, encodeId=855f14832316d, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
    2013-06-07 xue8602
  5. [GetPortalCommentsPageByObjectIdResponse(id=1697158, encodeId=fc24169e158a6, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Jul 31 18:53:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950736, encodeId=94e41950e366e, content=<a href='/topic/show?id=93089e161db' target=_blank style='color:#2F92EE;'>#门静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97161, encryptionId=93089e161db, topicName=门静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2978132, createdName=minzju5052, createdTime=Thu Mar 06 14:53:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057215, encodeId=40b9205e215d8, content=<a href='/topic/show?id=18982222db' target=_blank style='color:#2F92EE;'>#AJG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2222, encryptionId=18982222db, topicName=AJG)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2978132, createdName=minzju5052, createdTime=Tue Jan 28 22:53:00 CST 2014, time=2014-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955175, encodeId=8dc919551e59e, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Fri Jun 07 23:53:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264183, encodeId=2d7112641832c, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435135, encodeId=307a1435135c7, content=<a href='/topic/show?id=6d779e14916' target=_blank style='color:#2F92EE;'>#门静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97149, encryptionId=6d779e14916, topicName=门静脉)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483231, encodeId=855f14832316d, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1697158, encodeId=fc24169e158a6, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Jul 31 18:53:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950736, encodeId=94e41950e366e, content=<a href='/topic/show?id=93089e161db' target=_blank style='color:#2F92EE;'>#门静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97161, encryptionId=93089e161db, topicName=门静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2978132, createdName=minzju5052, createdTime=Thu Mar 06 14:53:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057215, encodeId=40b9205e215d8, content=<a href='/topic/show?id=18982222db' target=_blank style='color:#2F92EE;'>#AJG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2222, encryptionId=18982222db, topicName=AJG)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2978132, createdName=minzju5052, createdTime=Tue Jan 28 22:53:00 CST 2014, time=2014-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955175, encodeId=8dc919551e59e, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Fri Jun 07 23:53:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264183, encodeId=2d7112641832c, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435135, encodeId=307a1435135c7, content=<a href='/topic/show?id=6d779e14916' target=_blank style='color:#2F92EE;'>#门静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97149, encryptionId=6d779e14916, topicName=门静脉)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483231, encodeId=855f14832316d, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1697158, encodeId=fc24169e158a6, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Jul 31 18:53:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950736, encodeId=94e41950e366e, content=<a href='/topic/show?id=93089e161db' target=_blank style='color:#2F92EE;'>#门静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97161, encryptionId=93089e161db, topicName=门静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2978132, createdName=minzju5052, createdTime=Thu Mar 06 14:53:00 CST 2014, time=2014-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057215, encodeId=40b9205e215d8, content=<a href='/topic/show?id=18982222db' target=_blank style='color:#2F92EE;'>#AJG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2222, encryptionId=18982222db, topicName=AJG)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2978132, createdName=minzju5052, createdTime=Tue Jan 28 22:53:00 CST 2014, time=2014-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955175, encodeId=8dc919551e59e, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Fri Jun 07 23:53:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264183, encodeId=2d7112641832c, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435135, encodeId=307a1435135c7, content=<a href='/topic/show?id=6d779e14916' target=_blank style='color:#2F92EE;'>#门静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97149, encryptionId=6d779e14916, topicName=门静脉)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483231, encodeId=855f14832316d, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Sun May 05 00:53:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]

相关资讯

J Biol Chem:研究发现HCV损害肝脏的线索

       南加州大学的研究人员已经发现了丙型肝炎病毒进入肝细胞的触发机制——该机制揭示这种严重的和可能致命的病毒怎样开始损害肝脏。该研究结果,发表在生物化学杂志,这项研究可以给科学家指明今后病毒治疗的发展方向。        在丙型肝炎病毒(HCV)感染的早期阶段,研究人员发现,该病毒结合到肝细胞表面的受

Liver int:一单位血小板对凝血状态影响甚微

肝硬化患者因存在脾功能亢进,血小板破坏增加,通常存在血小板计数减少,导致自发性出血风险增加。为了改善这一状况,临床上通常给予一单位(即一标准成人血小板量)的输注以预防出血,但究竟一标准成人血小板能起到多大的作用?是否能够有效改善患者的凝血状态?如何输注效果会更好?这些仍不清楚。意大利米兰安吉洛比安奇博诺米血友病和血栓形成研究中心Armando Tripodi等人对于上述问题进行了一系列研究,发现输

J HEPATOL:博赛泼维药物组合治晚期纤维化/肝硬化安全有效

       源自丙型肝炎病毒(HCV)基因1型的晚期纤维化/肝硬化的患者,对聚乙二醇干扰素-利巴韦林联合博赛泼维(Boceprevir)有时会有持续的病毒学应答(SVR),早期结果可以反映应答,研究人员报道。        布鲁诺博士在电子邮件写道:“大多数肝硬化患者(METAVIR评分分级 F4),HCV

Lancet:长期替诺福韦酯治疗可逆转慢乙肝肝硬化

       一项为期5年的随访研究发现,对于慢性乙肝病毒感染患者,长期(至少5年)应用替诺福韦酯治疗安全有效。长期抑制乙肝病毒可以逆转肝纤维化和肝硬化。该论文于2012年12月10日在线发表于《柳叶刀》杂志。   长期抑制乙肝病毒的复制是否对于慢性乙肝病毒感染相关的晚期肝纤维化的逆转有益尚不清楚。   该研究旨在评价慢性乙型肝炎感染治疗

PNAS:研究发现利尿剂新的治疗基因靶标

  近日,辛辛那提大学(UC)研究人员已经确定了利尿剂治疗那些如充血性心脏衰竭、肝硬化或肾功能衰竭患者新的治疗靶标。 这些结果发表在7月30日的PNAS期刊上,这可能会导致25年来第一个新的利尿剂治疗可以帮助利尿剂抵抗的患者。     Manoocher Soleimani医师说利尿剂的作用是增加尿量帮助患者处理自己多余的液体,因为他们的肾脏是无法做到的。在过去的几十年中,医生已使用